MPPE1 and neoplasm: Our results show that delivery of PIB factors to tumors in situ and tumor spheroids drives a cDC1 cell fate at phenotypic, transcriptomic, and functional levels, which results in TME re-modeling, induction of tumor-specific T cell responses and leads to systemic and long-lasting antitumor immunity.